Home   |   About AHDI   |   Shopping Cart   |   Contact Us   |   Sign In   |   Join
Webinar: Alzheimer’s Disease: What You Need to Know
Tell a Friend About This EventTell a Friend
Webinar: Alzheimer’s Disease: What You Need to Know

 Export to Your Calendar 9/30/2020
When: September 30, 2020
10:00-11:00 a.m. Pacific/1:00-2:00 p.m. Eastern
Where: United States
Contact: Kristin Wall


Online registration is closed.
« Go to Upcoming Event List  

Title: Alzheimer’s Disease: What You Need to Know

Presenter: Rebecca Edelmayer, PhD

Date: September 30, 2020

Time: 10:00-11:00 a.m. Pacific/1:00-2:00 p.m. Eastern

CEC: 1 Clinical Medicine (CM)

Cost: $5 Student Members/$15 Members/$25 List Price

 

Session Description

Designed for non-physician healthcare professionals, this learning activity will cover current knowledge related to clinical manifestations of Alzheimer’s and other dementias, including signs/symptoms, diagnosis, current treatment options, prognosis, and an update on recent research that may soon change diagnosis and care in medical settings.

 

Learning Objectives

  1. Differentiate the related concepts of Alzheimer’s disease and clinical dementia.
  2. Understand the clinical symptoms associated with Alzheimer’s and dementia.
  3. Recognize the current medications available, along with their limitations.
  4. Learn the difference between Mild Cognitive Impairment (MCI) and dementia.
  5. Learn how biomarkers are used in dementia research and clinical care.

 

About the Speaker

Dr. Edelmayer leads efforts to accelerate the scientific agenda of the Alzheimer’s Association through the creation and delivery of ongoing research education. She engages with more than 75 Alzheimer’s Association chapters across the country, ensuring that staff and the public are aware of the importance of medical research and the Association’s crucial role in advancing research to improve the lives of individuals living with dementia and their care partners. In addition, Dr. Edelmayer manages initiatives uniting researchers and clinicians with leaders of industry, regulatory agencies and the government on topics related to blood-based biomarker testing, use of digital health technologies and biotech approaches in studying dementia.

 

Attendance is limited to the first 100 registrants! Registrants will automatically receive the recorded webinar in the event you cannot attend live.

Association Management Software Powered by YourMembership  ::  Legal